+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid therapy in chronic active hepatitis



Ursodeoxycholic acid therapy in chronic active hepatitis



Postgraduate Medical Journal 66(779): 781-783



A 41 year old woman developed chronic active hepatitis with prominent cholestasis. She was treated with prednisolone over 3 years with symptomatic benefit and improvement in serum biochemistry. However, various steroid-related side effects were encountered and steatorrhoea eventually occurred with very troublesome nocturnal diarrhoea. Therapy with ursodeoxycholic acid 750 mg daily was started. Serum alanine aminotransferase and gamma-glutamyl transferase normalized for the first time since her illness began. Steatorrhoea was abolished. There was good control of symptoms as prednisolone therapy was gradually reduced. However, when prednisolone was completely withdrawn there was a prompt biochemical deterioration. Addition of low-dose azathioprine has maintained normal blood tests over 24 months without return of the original symptoms. There are no side effects of ursodeoxycholic acid in subjects without gallstones and this agent may be effective treatment for cholestatic liver disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144910

Download citation: RISBibTeXText

PMID: 2235818

DOI: 10.1136/pgmj.66.779.781


Related references

Positive effect of ursodeoxycholic acid therapy on liver enzymes in chronic active autoimmune hepatitis: A pilot study. Leber Magen Darm 26(6): 310-313, 1996

Long term treatment with ursodeoxycholic acid in patients with chronic active hepatitis. Current Therapeutic Research 50(5): 635-642, 1991

Ursodeoxycholic acid udca in chronic active hepatitis results of a controlled trial. Journal of Hepatology 13(SUPPL 2): S104, 1991

Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid. Zeitschrift für Gastroenterologie 30 Suppl 1: 49-54, 1992

Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection. Hepatology Research 39(1): 21-30, 2008

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study. Hepatology 13(2): 339-344, 1991

Ursodeoxycholic acid udca improves serum albumin levels in chronic active hepatitis. Gastroenterology 98(5 PART 2): A606, 1990

Ursodeoxycholic acid udca improves serum protein level in patients with chronic active hepatitis. Hepatology 12(4 PART 2): 998, 1990

Effect of ursodeoxycholic acid udca on liver function lf in patients with chronic active hepatitis and cirrhosis. European Journal of Clinical Investigation 20(2 PART 2): A62, 1990

Ursodeoxycholic acid in the therapy of chronic hepatitis after treatment with interferon. Minerva Medica 91(7-8): 141-145, 2001

Effect of ursodeoxycholic acid udca on serum enzymes and liver histology in patients with chronic active hepatitis cah. Journal of Hepatology 13(SUPPL 2): S92, 1991

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Digestive Diseases and Sciences 30(7): 642-649, 1985

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and 2 years follow up a pilot study. Digestive Diseases & Sciences 30(7): 642-649, 1985

Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease. Internal Medicine 41(10): 774-779, 2002

A case of primary biliary cirrhosis associated with chronic active hepatitis C improved by the injection of interferon and the administration of ursodeoxycholic acid. Japanese Journal of Gastroenterology 90(9): 2152-2156, 1993